Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome
- PMID: 21085895
- DOI: 10.1590/s0100-879x2010007500119
Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome
Abstract
Rubinstein-Taybi syndrome (RTS) is a rare developmental disorder characterized by craniofacial dysmorphisms, broad thumbs and toes, mental and growth deficiency, and recurrent respiratory infections. RTS has been associated with CREBBP gene mutations, but EP300 gene mutations have recently been reported in 6 individuals. In the present study, the humoral immune response in 16 RTS patients with recurrent respiratory infections of possible bacterial etiology was evaluated. No significant differences between patients and 16 healthy controls were detected to explain the high susceptibility to respiratory infections: normal or elevated serum immunoglobulin levels, normal salivary IgA levels, and a good antibody response to both polysaccharide and protein antigens were observed. However, most patients presented high serum IgM levels, a high number of total B cell and B subsets, and also high percentiles of apoptosis, suggesting that they could present B dysregulation. The CREBBP/p300 family gene is extremely important for B-cell regulation, and RTS may represent an interesting human model for studying the molecular mechanisms involved in B-cell development.
Similar articles
-
Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections.Allergy Asthma Proc. 2006 May-Jun;27(3):281-4. doi: 10.2500/aap.2006.27.2864. Allergy Asthma Proc. 2006. PMID: 16913274
-
Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.Clin Dysmorphol. 2016 Oct;25(4):135-45. doi: 10.1097/MCD.0000000000000143. Clin Dysmorphol. 2016. PMID: 27465822
-
Letter to the Editor: A Novel Mutation in the CREBBP Gene of a Korean Girl with Rubinstein-Taybi syndrome.Ann Clin Lab Sci. 2015 Summer;45(4):458-61. Ann Clin Lab Sci. 2015. PMID: 26275701
-
Rubinstein-Taybi syndrome: clinical and molecular overview.Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415. Expert Rev Mol Med. 2007. PMID: 17942008 Review.
-
[Rubinstein-Taybi syndrome].Arch Pediatr. 1994 Jul;1(7):681-3. Arch Pediatr. 1994. PMID: 7987469 Review. French.
Cited by
-
KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.Clin Epigenetics. 2020 Jan 10;12(1):10. doi: 10.1186/s13148-019-0802-2. Clin Epigenetics. 2020. PMID: 31924266 Free PMC article. Review.
-
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.J Med Genet. 2024 May 21;61(6):503-519. doi: 10.1136/jmg-2023-109438. J Med Genet. 2024. PMID: 38471765 Free PMC article. Review.
-
Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.Ital J Pediatr. 2015 Jan 20;41:4. doi: 10.1186/s13052-015-0110-1. Ital J Pediatr. 2015. PMID: 25599811 Free PMC article. Review.
-
Further peer review failures.Clinics (Sao Paulo). 2011;66(10):1833. doi: 10.1590/s1807-59322011001000025. Clinics (Sao Paulo). 2011. PMID: 22012059 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous